{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:14Z","timestamp":1786120274550,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/mbc.0b013e32834d7ce3","type":"journal-article","created":{"date-parts":[[2011,10,22]],"date-time":"2011-10-22T02:30:45Z","timestamp":1319250645000},"page":"45-50","source":"Crossref","is-referenced-by-count":20,"title":["The KIR2DS2\/DL2 genotype is associated with adult persistent\/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms"],"prefix":"10.1097","volume":"23","author":[{"given":"Jamie P.","family":"Nourse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod","family":"Lea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Brighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Marlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher K.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"issue":"Suppl 1","key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/00043426-200312001-00004","article-title":"Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.","volume":"25","author":"Crow","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","article-title":"Structurefunction of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations.","volume":"132","author":"Campbell","year":"2011","journal-title":"Immunology"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1073\/pnas.080588597","article-title":"Plasticity in the organization and sequences of human KIRILT gene families.","volume":"97","author":"Wilson","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1600-065X.2001.1810105.x","article-title":"Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules.","volume":"181","author":"Boyington","year":"2001","journal-title":"Immunol Rev"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.169.6.2818","article-title":"Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.","volume":"169","author":"Martin","year":"2002","journal-title":"J Immunol"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2337\/diabetes.52.10.2639","article-title":"KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.","volume":"52","author":"van der Slik","year":"2003","journal-title":"Diabetes"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood-2009-10-250134","article-title":"Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.","volume":"115","author":"Stern","year":"2010","journal-title":"Blood"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/35018508","article-title":"The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.","volume":"406","author":"Sondermann","year":"2000","journal-title":"Nature"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","article-title":"Fc gammaRIIIa-158 VF polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48LRH phenotype.","volume":"90","author":"Koene","year":"1997","journal-title":"Blood"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1182\/blood-2007-01-070656","article-title":"Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcgammaRIIIa-158 VV and VF polymorphism.","volume":"110","author":"Hatjiharissi","year":"2007","journal-title":"Blood"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2249.2000.01208.x","article-title":"The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.","volume":"120","author":"Fijen","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"R15-7-20210203","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1093\/hmg\/ddl408","article-title":"Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses.","volume":"15","author":"Keen-Kim","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R17-7-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-1759(03)00123-6","article-title":"Rapid single-step FCGR3A genotyping based on SYBR Green I fluorescence in real-time multiplex allele-specific PCR.","volume":"277","author":"DallOzzo","year":"2003","journal-title":"J Immunol Methods"},{"key":"R18-7-20210203","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1399-0039.2007.00923.x","article-title":"Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments.","volume":"70","author":"Vilches","year":"2007","journal-title":"Tissue Antigens"},{"key":"R19-7-20210203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2141.2003.04033.x","article-title":"Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura.","volume":"120","author":"Carcao","year":"2003","journal-title":"Br J Haematol"},{"key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.exger.2004.05.003","article-title":"Investigation of KIR diversity in immunosenescence and longevity within the Irish population.","volume":"39","author":"Maxwell","year":"2004","journal-title":"Exp Gerontol"},{"key":"R21-7-20210203","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1007\/s00277-009-0865-9","article-title":"Genetic studies in pediatric ITP: outlook, feasibility, and requirements.","volume":"89","author":"Bergmann","year":"2010","journal-title":"Ann Hematol"},{"key":"R22-7-20210203","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity.","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"key":"R23-7-20210203","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.hoc.2009.08.007","article-title":"Infections, antigen-presenting cells, T cells, and immune tolerance: their role in the pathogenesis of immune thrombocytopenia.","volume":"23","author":"Semple","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"R24-7-20210203","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2141.2006.06024.x","article-title":"The pathogenesis of immune thrombocytopaenic purpura.","volume":"133","author":"Cooper","year":"2006","journal-title":"Br J Haematol"},{"key":"R25-7-20210203","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2141.2010.08412.x","article-title":"Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.","volume":"152","author":"Toltl","year":"2011","journal-title":"Br J Haematol"},{"key":"R26-7-20210203","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","article-title":"Human diversity in killer cell inhibitory receptor genes.","volume":"7","author":"Uhrberg","year":"1997","journal-title":"Immunity"},{"key":"R27-7-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.exphem.2009.12.007","article-title":"B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.","volume":"38","author":"Borgerding","year":"2010","journal-title":"Exp Hematol"},{"key":"R28-7-20210203","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2007-03-079913","article-title":"Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura.","volume":"111","author":"Breunis","year":"2008","journal-title":"Blood"},{"key":"R29-7-20210203","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1365-2141.2001.02807.x","article-title":"Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study.","volume":"113","author":"Foster","year":"2001","journal-title":"Br J Haematol"},{"key":"R30-7-20210203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2141.2001.03109.x","article-title":"Involvement of Fc gamma receptor polymorphism in the therapeutic response of idiopathic thrombocytopenic purpura.","volume":"115","author":"Fujimoto","year":"2001","journal-title":"Br J Haematol"},{"key":"R31-7-20210203","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"R32-7-20210203","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood-2007-02-074716","article-title":"NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"R33-7-20210203","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2009-07-229815","article-title":"Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.","volume":"115","author":"Zaja","year":"2010","journal-title":"Blood"},{"key":"R34-7-20210203","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2008-01-131029","article-title":"Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.","volume":"112","author":"Godeau","year":"2008","journal-title":"Blood"},{"key":"R35-7-20210203","first-page":"305","article-title":"Long-term management of chronic immune thrombocytopenic purpura in adults.","volume":"3","author":"Palau","year":"2010","journal-title":"Int J Gen Med"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-201201000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:23:27Z","timestamp":1786047807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201201000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32834d7ce3","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}